Unilife Hires Intel Marketing Executive Kevin Sellers as Senior Vice President of Marketing and Communications
PR Newswire - Thu Dec 11, 8:00AM CST
Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced the appointment of Kevin Sellers, a veteran marketing and communications executive at Intel Corporation, to the post of Senior Vice President, Marketing and Communications. Sellers will report to Unilife Chairman and CEO Alan Shortall, with responsibility for investor relations, global marketing and public relations
UNIS: 3.19 (+0.03), INTC: 37.44 (+0.01)
Unilife Signs Long-Term Commercial Supply Agreement for Use of Depot-ject(TM) Delivery System with Approved Ocular Injection Drug
PR Newswire - Tue Dec 02, 7:00AM CST
Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer and supplier of injectable drug delivery systems, announced today the signing of a worldwide 10 year Commercial Supply Agreement with a global pharmaceutical company for the use of the Depot-ject(TM) delivery system with an approved ocular injection therapy.
UNIS: 3.19 (+0.03)
Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd
PR Newswire - Tue Nov 25, 3:05PM CST
Unilife Corporation (NASDAQ:UNIS, ASX: UNS), a designer, manufacturer and supplier of injectable drug delivery systems, today announced that its Chairman and CEO, Alan Shortall, is scheduled to present at the Piper Jaffray 26th Annual Healthcare Conference at the New York Palace Hotel at 8:30 a.m. EST on Tuesday, December 2, 2014.
UNIS: 3.19 (+0.03)
Unilife and Flextronics Enter Into Global Strategic Alliance
PR Newswire - Thu Nov 13, 7:30AM CST
Unilife Corporation (NASDAQ:UNIS, ASX: UNS), a designer, manufacturer and supplier of injectable drug delivery systems, today announced the signing of a Global Strategic Alliance Agreement with Flextronics (NASDAQ: FLEX), a leading end-to-end supply chain solutions company, as its global strategic partner to further expand the production capacity and scale-up capability of Unilife's product portfolio.
FLEX: 11.25 (+0.11), UNIS: 3.19 (+0.03)
Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST
FSM: 4.31 (+0.10), HEAR: 2.98 (+0.01), JRJC: 5.81 (-0.11), CVO: 2.13 (-0.03), AAOI: 10.75 (-0.05), UNIS: 3.19 (+0.03), HIIQ: 7.51 (-0.16), CYAN: 7.00 (+0.50), PTX: 9.05 (+0.28), TRMR: 2.74 (-0.08), PRKR: 0.90 (+0.04), SUMR: 3.10 (+0.06), VSLR: 8.97 (+0.18), RVP: 4.84 (+0.19), ASCMA: 53.62 (+0.92), ICUI: 83.38 (+1.63), CALL: 7.83 (-0.07), DMD: 5.96 (-0.09), AST: 3.22 (+0.01), ASEI: 51.61 (+0.05)
Unilife Corporation Submits its 10-Q for Filing
PR Newswire - Tue Nov 11, 8:18AM CST
Unilife Corporation ("Unilife" or "Company"
UNIS: 3.19 (+0.03)
Unilife beats 1Q profit forecasts
Automated Insights - Tue Nov 11, 4:11AM CST
YORK, Pa. (AP) _ Unilife Corp. (UNIS) on Tuesday reported a loss of $22.3 million in its fiscal first quarter.
UNIS: 3.19 (+0.03)
Unilife's (UNIS) CEO Alan Shortall on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:55PM CST
UNIS: 3.19 (+0.03)
/C O R R E C T I O N -- Unilife Corporation/
PR Newswire - Mon Nov 10, 4:58PM CST
In the news release, Unilife Corporation Announces Financial Results For the First Quarter of Fiscal Year 2015, issued 10-Nov-2014 by Unilife Corporation over PR Newswire, we are advised by the company that there were multiple changes throughout the release. The complete, corrected release follows:
UNIS: 3.19 (+0.03)
Unilife Corporation misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:25PM CST
UNIS: 3.19 (+0.03)
Unilife (UNIS) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST
UNIS: 3.19 (+0.03)
Unilife Corporation Announces Financial Results For the First Quarter of Fiscal Year 2015
PR Newswire - Mon Nov 10, 3:15PM CST
Unilife Corporation ("Unilife" or "Company"
UNIS: 3.19 (+0.03)
The Zacks Analyst Blog Highlights: AbbVie, Shire, Medtronic, Unilife and Derma Sciences
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the AbbVie Inc. (NYSE:ABBV-Free Report), Shire plc (Nasdaq:SHPG-Free Report), Medtronic Inc. (NYSE:MDT-Free Report), Unilife Corporation (Nasdaq:UNIS-Free Report) and Derma Sciences Inc. (Nasdaq
DSCI: 9.08 (+0.43), UNIS: 3.19 (+0.03), MDT: 74.08 (+0.31), SHPG: 209.29 (+0.07)
Should You Buy Unilife Corporation (UNIS) Ahead of Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:51AM CST
Investors are always looking for stocks that are poised to beat at earnings season and Unilife Corporation (UNIS) may be one such company.
UNIS: 3.19 (+0.03)
Top 2 MedTech Stocks, Poised to Gain on Earnings this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:36AM CST
Medical device is one of such sectors which are projected to be highly affected by the midterm election results.
DSCI: 9.08 (+0.43), MDT: 74.08 (+0.31), UNIS: 3.19 (+0.03), COV: 103.35 (+0.57), SHPG: 209.29 (+0.07), ABBV: 66.21 (+1.86), WAG: 76.67 (+0.16)
Unilfe: New Contracts Will Triple Share Price
RightEdge Analytics - Seeking Alpha - Tue Nov 04, 7:43AM CST
Update: This article is to update the recent announcements and run up in share price since the last article that we published on Unilife (NASDAQ: UNIS ) on September 19, 2014 . Since this article UNIS has increased in value by about 50%. This is...
UNIS: 3.19 (+0.03)
Unilife Corporation To Announce Financial Results For Fiscal Year 2015 First Quarter On Monday, November 10, 2014
PR Newswire - Thu Oct 30, 5:00PM CDT
Unilife Corporation ("Unilife" or "Company"
UNIS: 3.19 (+0.03)
Unilife Up 6.6%, Shares Break Through Resistance (UNIS)
Comtex SmarTrend(R) - Wed Oct 29, 10:08AM CDT
Unilife (NASDAQ:UNIS) is one of today's best performing low-priced stocks, up 6.6% to $3.85 on 1.2x average daily volume. Unilife has traded 1.9 million shares thus far today, vs. average volume of 1.6 million shares per day. The stock has outperformed the Dow (6.6% to the Dow's -0.0%) and outperformed the S&P 500 (6.6% to the S&P's -0.0%) during today's trading.
UNIS: 3.19 (+0.03)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 8:15AM CDT
CAMT: 3.05 (+0.03), ORB: 26.89 (+0.23), UNIS: 3.19 (+0.03), ALLY: 23.87 (-0.02), FB: 80.77 (+0.16), AMCC: 6.63 (+0.09), INVN: 16.22 (+0.27), AKS: 5.76 (+0.11), NBG: 1.95 (+0.06), RFMD: 16.59 (+0.29), BLDP: 1.77 (+0.01), CARA: 9.78 (+0.02), GT: 28.22 (-0.05), HIVE: 4.82 (-0.02), MCGC: 3.95 (+0.02), IBIO: 0.68 (-0.04), BIOS: 6.37 (unch), UBA: 22.46 (-0.04), ARCP: 8.33 (unch), SNY: 46.35 (+0.50), STM: 7.69 (+0.09), X: 26.51 (+0.11)
Upgrade Alert for Unilife (UNIS)
Comtex SmarTrend(R) - Wed Oct 15, 7:03AM CDT
Unilife (NASDAQ:UNIS) was upgraded from Neutral to Buy at Ladenburg today. The stock closed yesterday at $3.37 on volume of 2.0 million shares, above average daily volume of 1.2 million. Unilife Corporation designs and manufactures medical devices. The Company produces retractable syringes. Unilife markets its products to pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities, and patients who self-administer prescription medication.
UNIS: 3.19 (+0.03)